weigh scale goliath outweigh balance bigger smaller even
Biotech

BioNTech’s B7-H3 ADC hits ph. 3 at half the size of Merck’s

BioNTech's DualityBio-partnered BNT324 achieved a median rPFS length of 11.3 months in heavily pretreated patients with mCRPC.
Angus Liu Feb 27, 2026 10:31pm
Person wearing a Lilly vest standing next to an Nvidia GPU

Lilly debuts Nvidia supercomputer with fanfare and focus

Feb 27, 2026 1:37pm
Wall Street IPO

Behind Generate's 'feverish' race to raise $400M IPO

Feb 27, 2026 3:36am
x

Fierce Biotech Layoff Tracker 2026: Merck, Viatris & more

Feb 27, 2026 2:45pm
phoenix rising from the flames

Atrium arises from Avidity buyout with $270M, preclinical assets

Feb 27, 2026 11:05am
fundraise tracker 2026

Fierce Biotech Fundraising Tracker '26: Atrium, Breeze & more

Feb 27, 2026 9:00am
More News

Sarepta CEO to step down as DM1 hits home—Chutes & Ladders

Feb 27, 2026 8:30am

Earendil pens $885M pact to use WuXi XDC's linker tech for ADCs

Feb 27, 2026 5:30am

Thermo Fisher unveils test for dosing of antirejection drug

Feb 27, 2026 5:20am

Senate hearing takes aim at FDA's rare disease review process

Feb 26, 2026 3:50pm